Current Report Filing (8-k)
April 29 2021 - 4:04PM
Edgar (US Regulatory)
0001725255
false
0001725255
2021-04-23
2021-04-23
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): April 23, 2021
AdaptHealth Corp.
(Exact name
of registrant as specified in its charter)
Delaware
|
|
001-38399
|
|
82-3677704
|
(State or other jurisdiction of
incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
220 West Germantown Pike, Suite 250
Plymouth Meeting, PA
|
|
19462
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
|
|
|
(610) 630-6357
|
|
(Registrant’s telephone number, including area code)
|
|
Not Applicable
|
|
(Former name or former address, if changed
since last report.)
|
|
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to
Section 12(b) of the Act:
Title of each
class
|
Trading Symbol(s)
|
Name of each
exchange on which registered
|
Class A Common Stock, par value $0.0001 per share
|
AHCO
|
The
Nasdaq Stock Market LLC
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01 Entry Into A Material Definitive Agreement.
On April 23, 2021, AdaptHealth LLC, a Delaware
limited liability company and wholly owned indirect subsidiary of AdaptHealth Corp. (the “Borrower”), entered into that certain
First Incremental Facility Amendment (the “Credit Agreement Amendment”) to the Credit Agreement, dated as of January 20, 2021
(as amended, restated, increased, extended, supplemented or otherwise modified from time to time, the “Credit Agreement”),
by and among the Borrower, the guarantors named therein, Regions Bank as administrative agent and collateral agent and the lenders party
thereto. The Credit Agreement Amendment (x) added an incremental term loan in the amount of $100,000,000 as a term loan under the Credit
Agreement, increasing the aggregate principal amount of the term loans incurred under the Credit Agreement to $800,000,000, and (y) increased
the aggregate revolving commitments available under the Credit Agreement from $250,000,000 to $450,000,000, in each case, with terms consistent
with the existing loans and commitments, respectively.
The foregoing description of the Credit Agreement
Amendment does not purport to be complete and is qualified in its entirety by the full text thereof, which is filed as Exhibit 10.1 hereto
and incorporated herein by reference.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation
Under an Off-Balance Sheet Arrangement of the Registrant.
The information set forth in Item 1.01 of this
report is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
104
|
Cover Page Data File (formatted as inline XBRL document)
|
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
Dated: April 29, 2021
|
|
|
|
|
|
|
AdaptHealth Corp.
|
|
|
|
|
|
By:
|
/s/ Jason Clemens
|
|
|
Name: Jason Clemens
|
|
|
Title: Chief Financial Officer
|
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Aug 2024 to Sep 2024
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Sep 2023 to Sep 2024